{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:28:57Z","timestamp":1787041737146,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25K02721"],"award-info":[{"award-number":["JP25K02721"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25K12042"],"award-info":[{"award-number":["JP25K12042"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25K19784"],"award-info":[{"award-number":["JP25K19784"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21ck0106688"],"award-info":[{"award-number":["JP21ck0106688"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22ck0106872"],"award-info":[{"award-number":["JP22ck0106872"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"DOI":"10.1007\/s00535-026-02502-5","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:12:32Z","timestamp":1787040752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytotoxic immune activity reflects a coordinated immune microenvironment and is associated with response to total neoadjuvant therapy in rectal cancer"],"prefix":"10.1007","author":[{"given":"Erina","family":"Haraguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimpei","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Shinozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senzo","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Chino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ippei","family":"Fukada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2321-1412","authenticated-orcid":false,"given":"Takashi","family":"Akiyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"2502_CR1","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","volume":"22","author":"T Conroy","year":"2021","unstructured":"Conroy T, Bosset JF, Etienne PL, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:702\u201315.","journal-title":"Lancet Oncol"},{"key":"2502_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","volume":"22","author":"RR Bahadoer","year":"2021","unstructured":"Bahadoer RR, Dijkstra EA, van Etten B, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:29\u201342.","journal-title":"Lancet Oncol"},{"key":"2502_CR3","doi-asserted-by":"publisher","first-page":"e180071","DOI":"10.1001\/jamaoncol.2018.0071","volume":"4","author":"A Cercek","year":"2018","unstructured":"Cercek A, Roxburgh CSD, Strombom P, et al. Adoption of total neoadjuvant therapy for locally advanced rectal cancer. JAMA Oncol. 2018;4:e180071.","journal-title":"JAMA Oncol"},{"key":"2502_CR4","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1200\/JCO.23.01208","volume":"42","author":"FS Verheij","year":"2024","unstructured":"Verheij FS, Omer DM, Williams H, et al. Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA trial. J Clin Oncol. 2024;42:500\u20136.","journal-title":"J Clin Oncol"},{"key":"2502_CR5","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","volume":"391","author":"MJM van der Valk","year":"2018","unstructured":"van der Valk MJM, Hilling DE, Bastiaannet E, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391:2537\u201345.","journal-title":"Lancet"},{"key":"2502_CR6","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41416-022-01842-2","volume":"127","author":"G Emons","year":"2022","unstructured":"Emons G, Auslander N, Jo P, et al. Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapy. Br J Cancer. 2022;127:766\u201375.","journal-title":"Br J Cancer"},{"key":"2502_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.114455","volume":"29","author":"C Corr\u00f2","year":"2026","unstructured":"Corr\u00f2 C, Carvalho JVM, Rapti M, et al. Integrative analysis of transcriptomic data reveals a predictive gene signature for chemoradiotherapy response in rectal cancer. iScience. 2026;29:114455.","journal-title":"iScience"},{"key":"2502_CR8","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1038\/s41591-022-01930-z","volume":"28","author":"WK Chatila","year":"2022","unstructured":"Chatila WK, Kim JK, Walch H, et al. Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer. Nat Med. 2022;28:1646\u201355.","journal-title":"Nat Med"},{"key":"2502_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ccell.2022.01.004","volume":"40","author":"AM Nicolas","year":"2022","unstructured":"Nicolas AM, Pesic M, Engel E, et al. Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer. Cancer Cell. 2022;40:168-84.e13.","journal-title":"Cancer Cell"},{"key":"2502_CR10","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/ng.3224","volume":"47","author":"C Isella","year":"2015","unstructured":"Isella C, Terrasi A, Bellomo SE, et al. Stromal contribution to the colorectal cancer transcriptome. Nat Genet. 2015;47:312\u20139.","journal-title":"Nat Genet"},{"key":"2502_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105228","volume":"106","author":"E Domingo","year":"2024","unstructured":"Domingo E, Rathee S, Blake A, et al. Identification and validation of a machine learning model of complete response to radiation in rectal cancer reveals immune infiltrate and TGF\u03b2 as key predictors. EBioMedicine. 2024;106:105228.","journal-title":"EBioMedicine"},{"key":"2502_CR12","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1158\/2767-9764.CRC-23-0502","volume":"4","author":"U Mahmood","year":"2024","unstructured":"Mahmood U, Blake A, Rathee S, et al. Stratification to neoadjuvant radiotherapy in rectal cancer by regimen and transcriptional signatures. Cancer Res Commun. 2024;4:1765\u201376.","journal-title":"Cancer Res Commun"},{"key":"2502_CR13","doi-asserted-by":"publisher","first-page":"e2252140","DOI":"10.1001\/jamanetworkopen.2022.52140","volume":"6","author":"T Akiyoshi","year":"2023","unstructured":"Akiyoshi T, Wang Z, Kaneyasu T, et al. Transcriptomic analyses of pretreatment tumor biopsy samples, response to neoadjuvant chemoradiotherapy, and survival in patients with advanced rectal cancer. JAMA Netw Open. 2023;6:e2252140.","journal-title":"JAMA Netw Open"},{"key":"2502_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13184642","author":"T Momma","year":"2021","unstructured":"Momma T, Okayama H, Kanke Y, et al. Validation of gene expression-based predictive biomarkers for response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13184642.","journal-title":"Cancers (Basel)"},{"key":"2502_CR15","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1158\/1078-0432.CCR-10-2915","volume":"17","author":"KH Brettingham-Moore","year":"2011","unstructured":"Brettingham-Moore KH, Duong CP, Greenawalt DM, et al. Pretreatment transcriptional profiling for predicting response to neoadjuvant chemoradiotherapy in rectal adenocarcinoma. Clin Cancer Res. 2011;17:3039\u201347.","journal-title":"Clin Cancer Res"},{"key":"2502_CR16","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1002\/ijc.70040","volume":"157","author":"E Haraguchi","year":"2025","unstructured":"Haraguchi E, Akiyoshi T, Noguchi T, et al. Differential effects of RAS mutations on chemoradiotherapy and total neoadjuvant therapy in locally advanced rectal cancer. Int J Cancer. 2025;157:2146\u201355.","journal-title":"Int J Cancer"},{"key":"2502_CR17","doi-asserted-by":"publisher","first-page":"4716","DOI":"10.1245\/s10434-023-13458-8","volume":"30","author":"T Yamaguchi","year":"2023","unstructured":"Yamaguchi T, Akiyoshi T, Fukunaga Y, et al. Adding induction chemotherapy before chemoradiotherapy with total mesorectal excision and selective lateral lymph node dissection for patients with poor-risk, locally advanced, mid-to-low rectal cancer may improve oncologic outcomes: a propensity score-matched analysis. Ann Surg Oncol. 2023;30:4716\u201324.","journal-title":"Ann Surg Oncol"},{"key":"2502_CR18","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s00595-025-03132-9","volume":"56","author":"K Sato","year":"2026","unstructured":"Sato K, Akiyoshi T, Noguchi T, et al. Induction chemotherapy followed by long-course chemoradiotherapy versus short-course radiotherapy followed by consolidation chemotherapy for achieving complete response in patients with locally advanced rectal cancer: a propensity-score matching study. Surg Today. 2026;56:256\u201366.","journal-title":"Surg Today"},{"key":"2502_CR19","volume-title":"TNM Classification of Malignant Tumours","author":"JDGM Brierley","year":"2017","unstructured":"Brierley JDGM, Wittekind C. TNM Classification of Malignant Tumours. 8th ed. Oxford: Wiley-Blackwell; 2017.","edition":"8"},{"key":"2502_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"2502_CR21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417\u201325.","journal-title":"Cell Syst"},{"key":"2502_CR22","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2502_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, et al. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS J Integr Biol. 2012;16:284\u20137.","journal-title":"OMICS J Integr Biol"},{"key":"2502_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-1-0716-0327-7_16","volume":"2120","author":"G Sturm","year":"2020","unstructured":"Sturm G, Finotello F, List M. Immunedeconv: an R package for unified access to computational methods for estimating immune cell fractions from bulk RNA-sequencing data. Methods Mol Biol. 2020;2120:223\u201332.","journal-title":"Methods Mol Biol"},{"key":"2502_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17:218.","journal-title":"Genome Biol"},{"key":"2502_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. XCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:220.","journal-title":"Genome Biol"},{"key":"2502_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","volume":"160","author":"MS Rooney","year":"2015","unstructured":"Rooney MS, Shukla SA, Wu CJ, et al. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell. 2015;160:48\u201361.","journal-title":"Cell"},{"key":"2502_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41467-017-02391-6","volume":"9","author":"M Schubert","year":"2018","unstructured":"Schubert M, Klinger B, Kl\u00fcnemann M, et al. Perturbation-response genes reveal signaling footprints in cancer gene expression. Nat Commun. 2018;9:20.","journal-title":"Nat Commun"},{"key":"2502_CR29","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, Dienstmann R, Wang X, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21:1350\u20136.","journal-title":"Nat Med"},{"key":"2502_CR30","doi-asserted-by":"publisher","first-page":"16618","DOI":"10.1038\/s41598-017-16747-x","volume":"7","author":"PW Eide","year":"2017","unstructured":"Eide PW, Bruun J, Lothe RA, et al. CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models. Sci Rep. 2017;7:16618.","journal-title":"Sci Rep"},{"key":"2502_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cells11233826","author":"KP Fabian","year":"2022","unstructured":"Fabian KP, Kowalczyk JT, Reynolds ST, et al. Dying of stress: chemotherapy, radiotherapy, and small-molecule inhibitors in immunogenic cell death and immunogenic modulation. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11233826.","journal-title":"Cells"},{"key":"2502_CR32","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1200\/JCO.23.02261","volume":"42","author":"F Xia","year":"2024","unstructured":"Xia F, Wang Y, Wang H, et al. Randomized phase II trial of immunotherapy-based total neoadjuvant therapy for proficient mismatch repair or microsatellite stable locally advanced rectal cancer (TORCH). J Clin Oncol. 2024;42:3308\u201318.","journal-title":"J Clin Oncol"},{"key":"2502_CR33","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.1158\/1078-0432.CCR-25-0975","volume":"31","author":"F Xia","year":"2025","unstructured":"Xia F, Chen Y, Zhou D, et al. Organ preservation via immunotherapy-based total neoadjuvant therapy in early low rectal cancer (TORCH-E): a multicenter, open-label, single-arm, phase II study. Clin Cancer Res. 2025;31:4976\u201384.","journal-title":"Clin Cancer Res"},{"key":"2502_CR34","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1158\/1078-0432.CCR-22-1102","volume":"28","author":"NC Fisher","year":"2022","unstructured":"Fisher NC, Byrne RM, Leslie H, et al. Biological misinterpretation of transcriptional signatures in tumor samples can unknowingly undermine mechanistic understanding and faithful alignment with preclinical data. Clin Cancer Res. 2022;28:4056\u201369.","journal-title":"Clin Cancer Res"},{"key":"2502_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-055140","volume":"12","author":"T Akiyoshi","year":"2022","unstructured":"Akiyoshi T, Shinozaki E, Taguchi S, et al. Non-operative management after chemoradiotherapy plus consolidation or sandwich (induction with bevacizumab and consolidation) chemotherapy in patients with locally advanced rectal cancer: a multicentre, randomised phase II trial (NOMINATE trial). BMJ Open. 2022;12:e055140.","journal-title":"BMJ Open"},{"key":"2502_CR36","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1158\/1078-0432.CCR-25-1242","volume":"31","author":"T Akiyoshi","year":"2025","unstructured":"Akiyoshi T, Shinozaki E, Maeda Y, et al. ctDNA longitudinal analysis during total neoadjuvant therapy and nonoperative management for locally advanced rectal cancer: a biomarker study from the NOMINATE trial. Clin Cancer Res. 2025;31:5188\u201397.","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02502-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-026-02502-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02502-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:12:33Z","timestamp":1787040753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-026-02502-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":36,"alternative-id":["2502"],"URL":"https:\/\/doi.org\/10.1007\/s00535-026-02502-5","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"27 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Fukada reported receiving honoraria for lectures from Chugai Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd., AstraZeneca K.K., Guardant Health Japan, K.K., Daiichi Sankyo Co., Ltd., and T-PEC Corporation, for consultation fees from SB TEMPUS Corp. outside of the submitted work. Dr. Ueno reported receiving honoraria for lectures from Astra Zeneca K.K., Daiichi Sankyo Co., Ltd., Exact Sciences Corp. and research grant from Eli Lilly Japan K.K. outside of the submitted work. Dr.Shinozaki reported receiving honoraria for lectures from Yakult Honsha, Merck Serono Co., Ltd., Chugai Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Eli Lilly, Taiho Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Ono Pharmaceutical Co., Ltd., and Guardant Health Pre Ltd. outside of the submitted work. No other disclosures were reported.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of the Cancer Institute Hospital, Japanese Foundation for Cancer Research (approval nos. 2013\u20131003 and 2021-GB-006). Written informed consent was obtained from all participants prior to inclusion.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}